- 180 Life Sciences Corp. (NASDAQ: ATNF)
- Aditxt Inc. (NASDAQ: ADTX)
- Augmedix Inc. (NASDAQ: AUGX)
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: XPHYF) (FSE: 4XT)
- Clene Inc. (NASDAQ: CLNN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN)
- DarioHealth Corp. (NASDAQ: DRIO)
- Fresh2 Group Ltd. (NASDAQ: FRES)
- Genprex Inc. (NASDAQ: GNPX)
- HeartBeam Inc. (NASDAQ: BEAT)
- IGC Pharma Inc. (NYSE American: IGC)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Longeveron Inc. (NASDAQ: LGVN)
- Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
- MetAlert Inc. (OTC: MLRT)
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF)
- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA)
- Nemaura Medical Inc. (NASDAQ: NMRD)
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)
- PaxMedica Inc. (NASDAQ: PXMD)
- Predictive Oncology (NASDAQ: POAI)
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA)
- Progressive Care Inc. (OTCQB: RXMD)
- QSAM Biosciences Inc. (OTCQB: QSAM)
- Renovaro BioSciences Inc. (NASDAQ: RENB)
- RVL Pharmaceuticals plc (NASDAQ: RVLP)
- Safety Shot Inc. (NASDAQ: SHOT)
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
- Silo Pharma Inc. (NASDAQ: SILO)
- SOHM Inc. (OTC: SHMN)
- Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)
- VistaGen Therapeutics Inc. (NASDAQ: VTGN)
- Vivos Therapeutics Inc. (NASDAQ: VVOS)